Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theo Rispens

Showing results (61-70 of 304) with videos related to

Pageof 31
Sort By:
The Journal of Allergy and Clinical Immunology|October 9, 2016
Neutralizing capacity of monoclonal and polyclonal anti-natalizumab antibodies: The immune response to antibody therapeutics preferentially targets the antigen-binding siteKarin A van Schie, Simone Kruithof, Pauline A van Schouwenburg, et al.
Journal of Immunological Methods|January 30, 2023
Drug-tolerant detection of anti-drug antibodies in an antigen-binding assay using europium chelate fluorescenceJolinde van Strien, Lisanne Dijk, Sadaf Atiqi, et al.
Frontiers in Immunology|January 23, 2024
Impact of structural modifications of IgG antibodies on effector functionsTimon Damelang, Maximilian Brinkhaus, Thijs L J van Osch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 24, 2017
Natalizumab-associated progressive multifocal leukoencephalopathy is not preceded by elevated drug concentrationsZoé LE van Kempen, Cyra E Leurs, Anke Vennegoor, et al.
Journal of Immunological Methods|February 1, 2015
Systematic comparison of drug-tolerant assays for anti-drug antibodies in a cohort of adalimumab-treated rheumatoid arthritis patientsKarien Bloem, Astrid van Leeuwen, Gerrit Verbeek, et al.
Plos One|July 7, 2011
Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopeniaTheresa Guhr, Judith Bloem, Ninotska I L Derksen, et al.
European Journal of Immunology|July 21, 2022
Improving naive B cell isolation by absence of CD45RB glycosylation and CD27 expression in combination with BCR isotypeJana Koers, Sabrina Pollastro, Simon Tol, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 30, 2022
Fingerprick blood samples to measure serum natalizumab concentrationsAlyssa A Toorop, Maurice Steenhuis, Floris C Loeff, et al.
Annals of the Rheumatic Diseases|December 12, 2013
Key findings towards optimising adalimumab treatment: the concentration-effect curveMieke F Pouw, Charlotte L Krieckaert, Michael T Nurmohamed, et al.
RMD Open|June 22, 2025
Different rheumatoid factor binding patterns distinguish between Sjögren's disease with or without associated RANienke Oskam, Gwenny Verstappen, Ninotska I L Derksen, et al.
Pageof 31

Showing results (61-70 of 304) with videos related to

Sort By:
Pageof 31
The Journal of Allergy and Clinical Immunology|October 9, 2016
Neutralizing capacity of monoclonal and polyclonal anti-natalizumab antibodies: The immune response to antibody therapeutics preferentially targets the antigen-binding siteKarin A van Schie, Simone Kruithof, Pauline A van Schouwenburg, et al.
Journal of Immunological Methods|January 30, 2023
Drug-tolerant detection of anti-drug antibodies in an antigen-binding assay using europium chelate fluorescenceJolinde van Strien, Lisanne Dijk, Sadaf Atiqi, et al.
Frontiers in Immunology|January 23, 2024
Impact of structural modifications of IgG antibodies on effector functionsTimon Damelang, Maximilian Brinkhaus, Thijs L J van Osch, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 24, 2017
Natalizumab-associated progressive multifocal leukoencephalopathy is not preceded by elevated drug concentrationsZoé LE van Kempen, Cyra E Leurs, Anke Vennegoor, et al.
Journal of Immunological Methods|February 1, 2015
Systematic comparison of drug-tolerant assays for anti-drug antibodies in a cohort of adalimumab-treated rheumatoid arthritis patientsKarien Bloem, Astrid van Leeuwen, Gerrit Verbeek, et al.
Plos One|July 7, 2011
Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopeniaTheresa Guhr, Judith Bloem, Ninotska I L Derksen, et al.
European Journal of Immunology|July 21, 2022
Improving naive B cell isolation by absence of CD45RB glycosylation and CD27 expression in combination with BCR isotypeJana Koers, Sabrina Pollastro, Simon Tol, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 30, 2022
Fingerprick blood samples to measure serum natalizumab concentrationsAlyssa A Toorop, Maurice Steenhuis, Floris C Loeff, et al.
Annals of the Rheumatic Diseases|December 12, 2013
Key findings towards optimising adalimumab treatment: the concentration-effect curveMieke F Pouw, Charlotte L Krieckaert, Michael T Nurmohamed, et al.
RMD Open|June 22, 2025
Different rheumatoid factor binding patterns distinguish between Sjögren's disease with or without associated RANienke Oskam, Gwenny Verstappen, Ninotska I L Derksen, et al.
Pageof 31